Indapta Therapeutics Inc. announced it has appointed Moya Daniels as Senior Vice President of Regulatory, Quality and Clinical Operations. Ms. Daniels most recently served as Senior Vice President of Regulatory and Quality at Aruvant Therapeutics. Previously she was Senior Vice President of Global Quality and GxP Compliance at Orchard Therapeutics, Officer & Head of Regulatory, Quality and Clinical Operations at Histogen, and Vice President of Regulatory Affairs at Fate Therapeutics.